Tokyo, Aug. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062661) titled 'Effects of Forward-Resistance Walking Using a Body Weight Support Walker on Hip Extension Angle During Gait in Patients After Unilateral Total Hip Arthroplasty' on Aug. 23.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Gunma University

Condition: Condition - After unilateral total hip arthroplasty Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to investigate changes in hip extension angle during gait before, during, and after forward-resistance walking using a body weight support walker in patients after unilateral total hip arthroplasty. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - The intervention is conducted on a single day. Participants perform three 10-m trials of forward-resistance walking using a body weight support walker. The body weight support function of the walker is not used. The forward-resistance function can be switched on or off, but the amount of resistance cannot be adjusted. Before forward-resistance walking using the body weight support walker, participants perform three 10-m trials of usual walking, followed by another three 10-m trials of usual walking immediately after forward-resistance walking.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1.Patients hospitalized at Maki Hospital who are 1 to 6 weeks after unilateral total hip arthroplasty. 2.Individuals who have received a sufficient explanation of the study and provided written informed consent. 3.Individuals who are able to walk independently or with a cane. 4.Individuals who are judged by the attending physician and physical therapist to be able to safely perform the walking tasks required in this study. Key exclusion criteria - 1.Patients in the immediate postoperative period after total hip arthroplasty who are unable to walk safely. 2.Individuals who are unable to complete the walking distance required in this study due to pain. 3.Individuals with an orthopedic or neurological condition of the non-operated lower limb that clearly affects gait (e.g., previous joint replacement, osteoarthritis requiring surgery, previous proximal femoral fracture, hemiplegia due to stroke, or Parkinson's disease). 4.Individuals who have difficulty understanding the study or following instructions due to cognitive impairment or higher brain dysfunction. 5.Individuals who are judged to be unable to walk safely due to neurological disease, severe cardiovascular disease, respiratory disease, or other conditions. 6.Individuals who are otherwise judged by the attending physician to be unsuitable for participation in the study. 7.Individuals who do not provide consent for video recording conducted in this study. Target Size - 25

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 09 Day Date of IRB - 2026 Year 08 Month 19 Day Anticipated trial start date - 2026 Year 08 Month 24 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071728

Disclaimer: Curated by HT Syndication.